B
urlington BioCenter Sold to Northeastern University

    Northeastern University has acquired the Burlington BioCenter, a 109,000-square-foot life sciences facility at 4 Burlington Woods Drive in Massachusetts. The university paid $33 million for the property, marking a significant expansion of its research and innovation efforts beyond its Boston campus.

    The sale was brokered by Newmark's Capital Markets team, who described the BioCenter as a unique asset with cutting-edge laboratory infrastructure and modern buildouts. Located just over a mile from Northeastern's existing Burlington campus, the facility will support homeland security and defense research, areas where the university is building global leadership.

    "The new building will expand the footprint and capabilities of our world-class faculty researchers," said Northeastern spokeswoman Renata Nyul. The BioCenter features high-performance lab infrastructure, including pH neutralization systems and backup power, making it one of the few fully operational life science facilities in the area.

    Northeastern's acquisition is part of a broader expansion strategy, which includes plans to replace Matthews Arena with a new multipurpose facility and secure approval for a 23-story residential tower on Columbus Avenue. The university's long-term vision is to establish itself as a leader in research and innovation, and its new Burlington acquisition is seen as a key step towards achieving this goal.

    The BioCenter's strategic location near major highways places it within Greater Boston's rapidly growing suburban biotech corridor, making it an ideal location for Northeastern's expanding research enterprise.